Rain Oncology Inc. Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rain Oncology Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2023.
  • Rain Oncology Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $436K, a 49.8% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Rain Oncology Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $436K +$145K +49.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $189K -$134K -41.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $224K -$131K -36.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $258K -$128K -33.2% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $291K -$125K -30% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $323K -$122K -27.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $355K -$118K -24.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $386K -$61K -13.6% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $416K Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $445K Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $473K Mar 31, 2021 10-Q 2021-05-25
Q4 2020 $447K Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.